Montréal enSanté V9N1 Hiver/Winter 2017 | Page 75

CENTRE UNIVERSITAIRE DE SANTÉ MCGILL MCGILL UNIVERSITY HEALTH CENTRE
g « Le projet pilote CSISS réalisé à l ’ unité B9 a permis de faire ressortir des méthodes d ’ amélioration de la qualité , et il a été extraordinaire de constater que , grâce à l ’ engagement de toute l ’ équipe du projet pilote CSISS , la transmission des infections des voies respiratoires supérieures a beaucoup diminué . Il est encore trop tôt pour dire si cette diminution se maintiendra tout au long de l ’ hiver , mais c ’ est un bon début , très encourageant ! »
« Les résultats du programme sont tout simplement phénoménaux », dit le D r Charles Frenette , directeur médical du Contrôle des infections au CUSM , en faisant remarquer que les unités concernées ont presque éradiqué l ’ acquisition de C . difficile et des ERV ( Entérocoques Résistants à la Vancomycine ) ainsi que la transmission du SARM ( Staphylococcus Aureus Résistant à la Méthicilline ).
« Nous n ’ aurions jamais cru qu ’ obtenir un tel résultat serait possible il y a deux ans , dit-il . Grâce à ce programme , non seulement nous rendons notre environnement plus sûr pour nos patients , mais nous réduisons également les coûts afin de mieux utiliser nos ressources limitées . » M g According to Aparna , the key to the success of the project is that " it draws on the strength and commitment of the wonderful individuals who work in the unit . We encourage and welcome ideas from everyone . For example , one day during a huddle we were discussing a C . difficile outbreak ( Clostridium difficile ), when one of our PABs , Jean-Claude Cadeau , said , ’ Oh , what about the stations with wipes outside each room ? They are hydrogen peroxide wipes . Maybe we should change those containers for the bleach wipes during an outbreak ?’ That was an excellent idea , and we adopted it ."
EMPOWERING STAFF
Tom Lombardi , section manager for Patient Transport , also sees benefits in empowering caregivers .
" We receive reports of the situation on each site every week . During the huddles , we write down ideas and the name of the person who came up with them . They feel like they ’ re being heard ."
For Anaïck and her colleagues , it was important to try different strategies with the teams and see what works .
" We work consistently , taking small steps ," she says . " We can adopt , adapt or abandon an idea , without investing a lot of money , time or resources . Most importantly , this project makes us aware of the impact our actions can have on the rates of nosocomial infections and , consequently , on the health of our patients .."
« Ce projet nous fait prendre conscience des conséquences de nos gestes sur le taux d ’ infections nosocomiales et , conséquemment , sur la santé de nos patients . »
“ This project makes us aware of the impact our actions can have on the rates of nosocomial infections and , consequently , on the health of our patients ."
— Anaïck Briand
ENCOURAGING RESULTS
According to Dr . Caroline Quach , pediatric infectious diseases and medical microbiologist and co-director of the MUHC Vaccine Study Centre of the Montreal Children ’ s Hospital ( MCH-MUHC ), staff at the MCH was already aware of the importance of infection prevention and control , with champions for each service and unit and regular hand hygiene auditing . Yet , there were still cases of healthcare-associated viral respiratory tract infections , even if multi-drug resistant organisms had not been transmitted .
" The CSISS piloted on B9 brought on quality improvement methods , and it has been amazing to see that , with the involvement of an entire team in the CSISS pilot project , there has been a marked decrease in transmission of upper respiratory infections . It is too early to tell if this will be sustained throughout the next winter season , but it is a good start and is quite encouraging !"
“ The outcomes obtained by the program have been just phenomenal ,” says Dr . Charles Frenette , MUHC medical director of Infection Control , noting that the units involved have almost eradicated acquisition of C . difficile and VRE ( Vancomycin-Resistant Enterococcus Faecalis ), and transmission of MRSA ( Methicillin-Resistant Staphylococcus Aureus ).
“ This is something we would have never thought possible two years ago ,” he says . “ Thanks to this program not only are we making our environment safer for our patients , but we are also saving costs to the hospital so that our limited resources can be better used .” M
WINTER 2017 MONTRÉAL enSANTÉ 73